Marinus Pharmaceuticals reported $70.78M in Loan Capital for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
ALKERMES ALKS:US USD 290.9M 633K
Amgen AMGN:US USD 37.16B 1.46B
Aptinyx Inc APTX:US USD 24.71M 211K
Biogen BIIB:US USD 6.28B 1.8M
Eisai 4523:JP JPY 84.91B 7M
Enanta Pharmaceuticals ENTA:US USD 1.42M 83K
Esperion Therapeutics ESPR:US USD 259.49M 407K
Intercept Pharmaceuticals ICPT:US USD 222.86M 491M
Marinus Pharmaceuticals MRNS:US USD 70.78M 430K
Ptc Therapeutics PTCT:US USD 981.61M 165K
Regeneron Pharmaceuticals REGN:US USD 2.7B 400K
Sarepta Therapeutics SRPT:US USD 1.54B 441.9M
Vertex Pharmaceuticals VRTX:US USD 442.3M 40M
YTE INCY:US USD 30.48M 681K